This service provides comprehensive toxicology studies to support the non-clinical development of healthcare products, including advanced therapies and chemical-based innovations. It covers a broad range of toxicological assessments such as acute, subacute, subchronic, and chronic in vivo toxicity, as well as reproductive and developmental toxicity, local tolerance, mutagenicity, and genotoxicity studies. In addition, the service includes tailored advisory support to define an appropriate toxicology roadmap aligned with the product profile and applicable regulatory requirements. The service is designed for EIC beneficiaries including public research organisations (universities and research institutes) and private sector entities (biotechnology and pharmaceutical companies) developing health-related products. It supports both exploratory non-Good Laboratory Practice (non-GLP) studies and fully compliant GLP toxicological studies required for product development and regulatory submissions. The duration of the service varies depending on the scope, study design, and regulatory strategy, ranging from short-term in vitro assessments to longer-term in vivo studies. The engagement begins with a protocol development phase, during which the study design is defined in close collaboration with the beneficiary. This is followed by study execution, data analysis, and the preparation of a final report. For GLP studies, all phases, including protocolisation, execution, analysis, and reporting, are conducted under strict quality control and audited in compliance with GLP requirements. All studies are performed under ISO 9001:2015-certified quality management systems, with GLP compliance applied where required. The service is delivered by in-house scientific teams, supported by internal auditors and regulatory experts to ensure high-quality outputs and adherence to international standards. As a result, beneficiaries receive a comprehensive final study report suitable for internal decision-making and/or regulatory use, enabling informed progression of their product development pipeline.
Services are provided on a fee-for-service basis. Quotes are prepared case by case according to study design, analytical complexity, sampling schedule, workload, consumables and equipment requirements. A tailored proposal is issued after technical discussion of the project. The hourly rate ranges from €100 to €265 and excludes materials, housing costs (where applicable), and equipment.
Final timelines depend on the study design, analytical workflow, sample collection plan, and analytics.
Access to Infrastructure & R&D Support
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.